Post job

Explore jobs

Find specific jobs

Explore careers

Explore professions

Best companies

Explore companies

Working at Intarcia Therapeutics

Zippia score 4.7

Overview

RevenueReviewsDemographicsCompetitorsCEO & Executives

Intarcia Therapeutics overview

Industry
Pharmaceutical Industry
Revenue
$70M
Headquarters
Employees
44
Founded in
Website
Organization type
Private
CEO
Kurt Graves
Social media
Intarcia Therapeutics is a biopharmaceutical company that develops therapies for diseases that require long-term chronic treatment. It offers DUROS, a drug delivery platform that stabilizes and delivers therapeutic proteins and peptides. Intarcia Therapeutics' products include OMEGA DUROS, an interferon delivery device for treating Hepatitis C and ITCA 650, a delivery device that provides type 2 diabetes patients with long-term steady state dosing of an incretin mimetic therapy. Additionally, it develops programs for treating obesity. David Franklin, James M. Ahlers, and Thomas Alessi founded BioMedicines in 1997 that became Intarcia Therapeutics in September 2004. Its headquarters is in Hayward in California with an additional office in Mountain View in California.
The staff at Intarcia Therapeutics come from unusually diverse demographic backgrounds. The company is 31.8% female and 64.6% ethnic minorities. Despite its diversity in other areas, Intarcia Therapeutics employees are noticeably lacking in political diversity. It has an unusually high proportion of employees who are members of the Democratic Party, at 83.0%. Employees seem to enjoy working in an otherwise diverse workplace that is dominated by members of the Democratic Party. Intarcia Therapeutics has great employee retention with staff members usually staying with the company for 4.6 years.
Intarcia Therapeutics is a small pharmaceutical company based in Boston, MA with only 44 employees and an annual revenue of $70.0M.

Intarcia Therapeutics's mission statement

To unleashing new ways to treat and prevent chronic disease.

In demand companies are hiring! Let Zippi apply for you!

Floating question marks illustration
-

Intarcia Therapeutics employee reviews

Be the first to review!

Do you work at Intarcia Therapeutics?

Help job seekers learn about working at Intarcia Therapeutics

On this page

Be the first to review Intarcia Therapeutics

Anonymously rate your employee experience

Your opinion can help other job seekers

Do you like working at Intarcia Therapeutics?

The team at Intarcia Therapeutics

  • The founders of Intarcia Therapeutics are Thomas Alessi, David Franklin and James Ahlers.
  • The key people at Intarcia Therapeutics are Kurt Graves, Thomas Alessi and David Franklin.
Key people
Kurt Graves
Thomas Alessi
David Franklin
James Ahlers

Intarcia Therapeutics rankings

Intarcia Therapeutics is ranked #84 on the Best Pharmaceutical companies to work for in America list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.

Read more about how we rank companies.

Rate Intarcia Therapeutics' promotion and raise policies.

Zippia waving zebra

Intarcia Therapeutics diversity

9.2
Diversity score
We calculated Intarcia Therapeutics’s diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Intarcia Therapeutics’s workforce.
Intarcia Therapeutics diversity summary. Zippia estimates Intarcia Therapeutics's demographics and statistics using a database of 30 million profiles. Zippia verifies estimates with BLS, Census, and current job openings data for accuracy. We calculated Intarcia Therapeutics's diversity score by measuring multiple factors, including the ethnic background, gender identity, and language skills of Intarcia Therapeutics's workforce.
  • Intarcia Therapeutics has 44 employees.
  • 32% of Intarcia Therapeutics employees are women, while 68% are men.
  • The most common ethnicity at Intarcia Therapeutics is White (35%).
  • 35% of Intarcia Therapeutics employees are Asian.
  • 17% of Intarcia Therapeutics employees are Hispanic or Latino.
  • The average employee at Intarcia Therapeutics makes $76,606 per year.
  • Intarcia Therapeutics employees are most likely to be members of the democratic party.
  • Employees at Intarcia Therapeutics stay with the company for 4.6 years on average.

Do you work at Intarcia Therapeutics?

Did Intarcia Therapeutics' compensation package meet your expectations?

Intarcia Therapeutics financial performance

9.1
Performance score

Highest paying Intarcia Therapeutics competitors

Compare Intarcia Therapeutics salaries to competitors, including Gilead Sciences, Vertex Pharmaceuticals, and Amgen. Employees at Gilead Sciences earn the highest average yearly salary of $99,828. The salaries at Vertex Pharmaceuticals average $95,952 per year, and the salaries at Amgen come in at $93,349 per year.
RankCompanyAverage salaryJobs
1$99,8280
2$95,9520
3$93,3490
4$90,3280
5$87,0920
6$85,5890
7$85,0080
8$84,4950
9$76,6860

Are you an executive, HR leader, or brand manager at Intarcia Therapeutics?

Claiming and updating your company profile on Zippia is free and easy.

Intarcia Therapeutics FAQs

Have more questions? See all answers to common company questions.

Search for jobs

Related companies

Related company jobs

Most in demand jobs

Related companies

    Updated March 14, 2024

    Zippia gives an in-depth look into the details of Intarcia Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Intarcia Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Intarcia Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Intarcia Therapeutics. The data presented on this page does not represent the view of Intarcia Therapeutics and its employees or that of Zippia.

    Intarcia Therapeutics may also be known as or be related to INTARCIA THERAPEUTICS, INC, Intarcia Therapeutics, Intarcia Therapeutics Inc. and Intarcia Therapeutics, Inc.